Cryopreservation and storage of reproductive genetic material of members of the Armed Forces on active duty

(a) In general The Secretary of Defense shall provide members of the Armed Forces on active duty with the opportunity for retrieval, testing, cryopreservation, shipping, and storage of their reproductive genetic material, such as sperm or oocytes, prior to— (1) deployment to a combat zone; or (2) a duty assignment that includes a hazardous assignment, including— (A) assignments resulting in exposure to perfluoroalkyl or polyfluoroalkyl substances; and (B) such other assignments as determined by the Secretary. (b) Period of time (1) In general The Secretary shall provide for the retrieval, testing, cryopreservation, shipping, and storage of reproductive genetic material of any member of the Armed Forces under subsection (a), at no cost to the member, until the date that is one year after the retirement, separation, or release of the member from the Armed Forces. (2) Continued cryopreservation and storage At the end of the one-year period specified in paragraph (1), the Secretary shall permit an individual whose reproductive genetic material was cryopreserved and stored as described in that paragraph to select, including pursuant to an advance medical directive or military testamentary instrument completed under subsection (c), one of the following options: (A) To continue such cryopreservation and storage in such facility with the cost of such cryopreservation and storage borne by the individual. (B) To transfer the material to a private cryopreservation and storage facility selected by the individual. (c) Advance medical directive and military testamentary instrument A member of the Armed Forces who elects to cryopreserve and store their reproductive genetic material under this section must complete an advance medical directive, as defined in section 1044c(b) of title 10, United States Code, and a military testamentary instrument, as defined in section 1044d(b) of such title, that explicitly specifies the use of their cryopreserved and stored reproductive genetic material if such member dies or otherwise loses the capacity to consent to the use of their cryopreserved and stored reproductive genetic material.